e-learning
resources
Stockholm 2007
Monday 17.09.2007
Impact of comorbidities in pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiac muscle mass and function are associated with altered body composition in patients with COPD
R. Sabit, C. Bolton, J. Edwards, R. Pettit, W. Evans, A. Fraser, D. Shale (Penarth, Cardiff, United Kingdom)
Source:
Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Session:
Impact of comorbidities in pulmonary rehabilitation
Session type:
Oral Presentation
Number:
2678
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sabit, C. Bolton, J. Edwards, R. Pettit, W. Evans, A. Fraser, D. Shale (Penarth, Cardiff, United Kingdom). Cardiac muscle mass and function are associated with altered body composition in patients with COPD. Eur Respir J 2007; 30: Suppl. 51, 2678
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006
Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Compartments distribution of body composition in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Nutritional and metabolic modulation in chronic obstructive pulmonary disease management
Source: Eur Respir J 2003; 22: 81S-86S
Year: 2003
Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005
Inflammatory markers in skeletal muscle of low and normal weight COPD patients
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
New modalities of nutritional aspects of pulmonary disease in the elderly
Source: Eur Respir Mon; 2009: 43: 240–255
Year: 2009
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective
Source: Eur Respir J 2003; 22: 2S-4S
Year: 2003
Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Early peripheral muscle structural and metabolic impairment in chronic obstructive pulmonary disease (COPD) patients cannot be considered as a consequence of sedentarity
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006
Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006
The influence of comorbid factors on muscle function, morphology and metabolism in COPD
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=99
Year: 2003
Handgrip strength reflects excersice capacity and systemic inflammation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 280-285
Year: 2003
Carnitine deficiency in chronic obstructive pulmonary disease patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Fat-free mass depletion and functional exercise capacity in COPD patients
Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept